FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 5.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $22,802,000 | +126.1% | 605,300 | +2.1% | 0.06% | +133.3% |
| Q4 2020 | $10,085,000 | +395.8% | 592,900 | +37.0% | 0.03% | +350.0% |
| Q3 2020 | $2,034,000 | -18.2% | 432,700 | +6.2% | 0.01% | -14.3% |
| Q2 2020 | $2,486,000 | +163.1% | 407,500 | -2.1% | 0.01% | +75.0% |
| Q1 2020 | $945,000 | -43.3% | 416,400 | +14.6% | 0.00% | 0.0% |
| Q4 2019 | $1,668,000 | +114.7% | 363,400 | +81.2% | 0.00% | +100.0% |
| Q3 2019 | $777,000 | -30.8% | 200,600 | +7.7% | 0.00% | -33.3% |
| Q2 2019 | $1,123,000 | -44.9% | 186,300 | +22.5% | 0.00% | -40.0% |
| Q1 2019 | $2,038,000 | +17.7% | 152,100 | -18.3% | 0.01% | 0.0% |
| Q4 2018 | $1,731,000 | -42.3% | 186,100 | -13.6% | 0.01% | -28.6% |
| Q3 2018 | $3,000,000 | +4.9% | 215,500 | +19.1% | 0.01% | -12.5% |
| Q2 2018 | $2,860,000 | -15.0% | 180,900 | -7.7% | 0.01% | -11.1% |
| Q1 2018 | $3,366,000 | +141.5% | 195,900 | +208.0% | 0.01% | +125.0% |
| Q4 2017 | $1,394,000 | +354.1% | 63,600 | +748.0% | 0.00% | +300.0% |
| Q3 2017 | $307,000 | +32.3% | 7,500 | -2.6% | 0.00% | 0.0% |
| Q2 2017 | $232,000 | -48.2% | 7,700 | -37.9% | 0.00% | 0.0% |
| Q1 2017 | $448,000 | -23.5% | 12,400 | +6.0% | 0.00% | -50.0% |
| Q4 2016 | $586,000 | -75.4% | 11,700 | -74.2% | 0.00% | -80.0% |
| Q3 2016 | $2,383,000 | +724.6% | 45,400 | +548.6% | 0.01% | +900.0% |
| Q2 2016 | $289,000 | -67.5% | 7,000 | -68.0% | 0.00% | -80.0% |
| Q1 2016 | $890,000 | +315.9% | 21,900 | +154.7% | 0.01% | +150.0% |
| Q2 2015 | $214,000 | -33.5% | 8,600 | -39.0% | 0.00% | 0.0% |
| Q1 2015 | $322,000 | – | 14,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|